{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:14:14Z","timestamp":1790802854667,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T00:00:00Z","timestamp":1657497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770378"],"award-info":[{"award-number":["81770378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800333"],"award-info":[{"award-number":["81800333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109024","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T14:51:23Z","timestamp":1657723883000},"page":"109024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis"],"prefix":"10.1016","volume":"110","author":[{"given":"Qi","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2022.109024_b0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0008-6363(01)00254-1","article-title":"Sudden cardiac death in young people with apparently normal heart","volume":"50","author":"Corrado","year":"2001","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0008-6363(03)00437-1","article-title":"Myocarditis and dilated cardiomyopathy: an inflammatory link","volume":"60","author":"Mason","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109024_b0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/20961790.2019.1595352","article-title":"Sudden cardiac death caused by myocarditis in persons aged 1\u201349 years: a nationwide study of 14 294 deaths in Denmark","volume":"4","author":"Lynge","year":"2019","journal-title":"Forensic Sci Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"9","key":"10.1016\/j.intimp.2022.109024_b0025","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","volume":"59","author":"Kindermann","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0030","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/s41598-022-05951-z","article-title":"Trends in myocarditis incidence, complications and mortality in Sweden from 2000 to 2014","volume":"12","author":"Fu","year":"2022","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2022.109024_b0035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurheartj\/ehs459","article-title":"Mononuclear cell secretome protects from experimental autoimmune myocarditis","volume":"36","author":"Hoetzenecker","year":"2015","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.intimp.2022.109024_b0040","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis\u2013diagnosis, treatment options, and current controversies","volume":"12","author":"Pollack","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"36","key":"10.1016\/j.intimp.2022.109024_b0045","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"48","key":"10.1016\/j.intimp.2022.109024_b0050","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1093\/eurheartj\/ehab420","article-title":"Effects of canagliflozin on human myocardial redox signalling: clinical implications","volume":"42","author":"Kondo","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2022.109024_b0060","doi-asserted-by":"crossref","unstructured":"N.R. Council, Guide for the Care and Use of Laboratory Animals., 8th edition. Washington (DC): National Academies Press (US). (2011).doi:10.17226\/12910.","DOI":"10.17226\/12910"},{"issue":"3","key":"10.1016\/j.intimp.2022.109024_b0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/cells9030700","article-title":"Haploinsufficient Rock1+\/- and Rock2+\/- Mice Are Not Protected from Cardiac Inflammation and Postinflammatory Fibrosis in Experimental Autoimmune Myocarditis","volume":"9","author":"Tkacz","year":"2020","journal-title":"Cells."},{"issue":"4","key":"10.1016\/j.intimp.2022.109024_b0070","doi-asserted-by":"crossref","first-page":"E492","DOI":"10.1152\/ajpendo.00401.2019","article-title":"Combined effect of canagliflozin and exercise training on high-fat diet-fed mice","volume":"318","author":"Tanaka","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.intimp.2022.109024_b0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/BCJ20210700","article-title":"Differential effect of canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice","volume":"479","author":"Otsuka","year":"2022","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.intimp.2022.109024_b0080","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.4049\/jimmunol.1103610","article-title":"Suppressor of cytokine signaling 1 DNA administration inhibits inflammatory and pathogenic responses in autoimmune myocarditis","volume":"189","author":"Tajiri","year":"2012","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109024_b0085","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/bph.13781","article-title":"IL-21 promotes myocardial ischaemia\/reperfusion injury through the modulation of neutrophil infiltration","volume":"175","author":"Wang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109024_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2018.10.022","article-title":"Gemcitabine nanoparticles promote antitumor immunity against melanoma","volume":"189","author":"Zhang","year":"2019","journal-title":"Biomaterials."},{"key":"10.1016\/j.intimp.2022.109024_b0095","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2147\/JIR.S348464","article-title":"Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-\u03baB Pathway","volume":"15","author":"Zhang","year":"2022","journal-title":"J Inflamm Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109024_b0100","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation."},{"issue":"49","key":"10.1016\/j.intimp.2022.109024_b0105","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.intimp.2022.109024_b0110","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.ijcard.2013.12.137","article-title":"Formation of the inflammasome in acute myocarditis","volume":"171","author":"Toldo","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2022.109024_b0115","doi-asserted-by":"crossref","first-page":"5551578","DOI":"10.1155\/2021\/5551578","article-title":"The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb\/c Mice","volume":"2021","author":"Chen","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"10","key":"10.1016\/j.intimp.2022.109024_b0120","doi-asserted-by":"crossref","first-page":"H1438","DOI":"10.1152\/ajpheart.00441.2014","article-title":"Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis","volume":"307","author":"Wang","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.intimp.2022.109024_b0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s11658-018-0125-x","article-title":"Tetrahydroxy stilbene glucoside alleviates palmitic acid-induced inflammation and apoptosis in cardiomyocytes by regulating miR-129-3p\/Smad3 signaling","volume":"24","author":"Zou","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2022.109024_b0130","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0135","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.intimp.2022.109024_b0140","doi-asserted-by":"crossref","unstructured":"Y. Ye, M. Bajaj, H.C. Yang, J.R. Perez-Polo, Y. Birnbaum, SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3\/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor, Cardiovasc. Drugs Ther. 31(2) (2017) 119-132.doi:10.1007\/s10557-017-6725-2.","DOI":"10.1007\/s10557-017-6725-2"},{"issue":"7","key":"10.1016\/j.intimp.2022.109024_b0145","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.4049\/jimmunol.1001718","article-title":"Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis","volume":"185","author":"Yuan","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109024_b0150","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101050RR","article-title":"Cardiac ectopic lymphoid follicle formation in viral myocarditis involving the regulation of podoplanin in Th17 cell differentiation","volume":"35","author":"Zhu","year":"2021","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.intimp.2022.109024_b0155","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"Sutton","year":"2006","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2022.109024_b0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10875-009-9355-z","article-title":"Th17 cells facilitate the humoral immune response in patients with acute viral myocarditis","volume":"30","author":"Yuan","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2022.109024_b0165","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2022.109024_b0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1165\/rcmb.2012-0423OC","article-title":"Interleukin-1 receptor and caspase-1 are required for the Th17 response in nitrogen dioxide-promoted allergic airway disease","volume":"48","author":"Martin","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2022.109024_b0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2018.09.007","article-title":"NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis","volume":"197","author":"Zhao","year":"2018","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109024_b0180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1753425919886643","article-title":"Leptin facilitates the differentiation of Th17 cells from MRL\/Mp-Fas lpr lupus mice by activating NLRP3 inflammasome","volume":"26","author":"Yu","year":"2020","journal-title":"Innate Immun."},{"issue":"11","key":"10.1016\/j.intimp.2022.109024_b0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.RES.86.11.1107","article-title":"Apoptosis and heart failure: A critical review of the literature","volume":"86","author":"Kang","year":"2000","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.intimp.2022.109024_b0190","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.amjcard.2009.05.041","article-title":"Apoptosis in patients with acute myocarditis","volume":"104","author":"Abbate","year":"2009","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109024_b0195","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/eurheartj\/ehp489","article-title":"Enterovirus-related activation of the cardiomyocyte mitochondrial apoptotic pathway in patients with acute myocarditis","volume":"31","author":"Vent\u00e9o","year":"2010","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41419-022-04533-1","article-title":"Cardiomyocyte IL-1R2 protects heart from ischemia\/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis","volume":"13","author":"Lin","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0205","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1038\/s41598-020-71449-1","article-title":"Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways","volume":"10","author":"Hasan","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0210","doi-asserted-by":"crossref","first-page":"14659","DOI":"10.1038\/s41598-020-71599-2","article-title":"Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK-Akt-eNOS pathway in the isoprenaline-induced oxidative stress model","volume":"10","author":"Hasan","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2022.109024_b0215","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.118.034222","article-title":"Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program","volume":"138","author":"R\u00e5dholm","year":"2018","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.intimp.2022.109024_b0220","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci."},{"key":"10.1016\/j.intimp.2022.109024_b0225","doi-asserted-by":"crossref","unstructured":"M. Trum, J. Riechel, S. Wagner, Cardioprotection by SGLT2 Inhibitors-Does It All Come Down to Na+?, Int. J. Mol. Sci. 22(15) (2021).doi:10.3390\/ijms22157976.","DOI":"10.3390\/ijms22157976"},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1124\/jpet.116.235069","article-title":"Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation","volume":"359","author":"Benetti","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0235","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006277","article-title":"Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure","volume":"13","author":"Byrne","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.intimp.2022.109024_b0240","article-title":"Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia\/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy","volume":"8","author":"Yu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109024_b0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cvr\/cvp190","article-title":"SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states","volume":"84","author":"Banerjee","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"48","key":"10.1016\/j.intimp.2022.109024_b0250","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1093\/eurheartj\/ehab519","article-title":"Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage","volume":"42","author":"Schiattarella","year":"2021","journal-title":"Eur. Heart J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:41:10Z","timestamp":1761586870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":50,"alternative-id":["S1567576922005082"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109024","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109024"}}